{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-22T12:23:59.967128+00:00",
  "news": [
    {
      "title": "With questions surrounding its gastric cancer drug, Amgen fills in some gaps - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1zNDBYYlJHWGU3TktJb1dpeUI0MkUxZFBpQklTbW1YT3BWWGw4RjVNSm5BOFBZTUJDamRmNUg3bVJaOHhqV21QZXF0MzdBOU14V1JVZVhseWNaSTI4M2NGa0xkbUJLVHhvel9SWDhYd251Y3l3aFAzZkZndw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMie0FVX3lxTE1zNDBYYlJHWGU3TktJb1dpeUI0MkUxZFBpQklTbW1YT3BWWGw4RjVNSm5BOFBZTUJDamRmNUg3bVJaOHhqV21QZXF0MzdBOU14V1JVZVhseWNaSTI4M2NGa0xkbUJLVHhvel9SWDhYd251Y3l3aFAzZkZndw?oc=5\" target=\"_blank\">With questions surrounding its gastric cancer drug, Amgen fills in some gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-10-20T14:52:07+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Amgen Inc. $AMGN Shares Acquired by D.A. Davidson & CO. - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQb1lQNVF1MVQ3NDBkd2ZRVXN3dVV2Wk5MNnIwbXJuVFM5V3JpOEp6QlRUcHZSWGZQRUI1bjloNUZRS1I4QXU5VGpuZEpvNndyeXhGUHRkcTdKX01lWWJEZlRDd2NRckIxUUwybnNJaU1nMmhtUFRHaUI2QmpRWXhmLWhEMmFqa0JyTW1pNmo0bGE0MmU2Umppai1SN2F3VEg1VVlBWFR2dDFMOGYzX1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxQb1lQNVF1MVQ3NDBkd2ZRVXN3dVV2Wk5MNnIwbXJuVFM5V3JpOEp6QlRUcHZSWGZQRUI1bjloNUZRS1I4QXU5VGpuZEpvNndyeXhGUHRkcTdKX01lWWJEZlRDd2NRckIxUUwybnNJaU1nMmhtUFRHaUI2QmpRWXhmLWhEMmFqa0JyTW1pNmo0bGE0MmU2Umppai1SN2F3VEg1VVlBWFR2dDFMOGYzX1E?oc=5\" target=\"_blank\">Amgen Inc. $AMGN Shares Acquired by D.A. Davidson & CO.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-22T11:05:16+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Will FDA Approval of TEZSPIRE for CRSwNP Expand Amgen's (AMGN) Treatment Portfolio and Market Reach? - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Will FDA Approval of TEZSPIRE for CRSwNP Expand Amgen's (AMGN) Treatment Portfolio and Market Reach?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-10-22T03:41:50+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5\" target=\"_blank\">US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-17T21:45:34+00:00",
      "source": "Reuters"
    },
    {
      "title": "AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5\" target=\"_blank\">AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-09-26T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "AstraZeneca, Amgen’s Tezspire approved in EU as add-on therapy - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUXRYaFdsZ0gxN1JlN002ME54LU1TN1hEa29qdnlramc4bm1DVlVpUUdpQlVFb2RWeGs1c3o3LWoyakhuZVFVMlVTRS1fSGF0Snl4RWFpRm1NWXBsdWZDUHdaSUNZZFhVM2hKanJoZklSX0V4S0xMQWJRY25pMkxnLTFuM2VEV3JELUV2NnRTTEw3bkdwWVRaRzlXQlFQdmkyTS1CTDdzeWU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUXRYaFdsZ0gxN1JlN002ME54LU1TN1hEa29qdnlramc4bm1DVlVpUUdpQlVFb2RWeGs1c3o3LWoyakhuZVFVMlVTRS1fSGF0Snl4RWFpRm1NWXBsdWZDUHdaSUNZZFhVM2hKanJoZklSX0V4S0xMQWJRY25pMkxnLTFuM2VEV3JELUV2NnRTTEw3bkdwWVRaRzlXQlFQdmkyTS1CTDdzeWU?oc=5\" target=\"_blank\">AstraZeneca, Amgen’s Tezspire approved in EU as add-on therapy</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-22T11:18:17+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Amgen's Bemarituzumab Shows Diminished Survival Benefit in Gastric Cancer in Latest ESMO Readout - Precision Medicine Online",
      "link": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQWUh1ZHFYWXhxVHp3Sjd4TG1XOHJTbHdWLS1kYk1GMVdscXlxR0ZkMUFNcFRNT1Q3eDlEMDBOWEZtV3c5dlUzUjVJXzJzTElCbW5lQkwyODhBUW9xT2V6NlpLNkpTOHJGYXpwRmNVVkRySDFKbjRHSVZfenNqWmFxLVZRcXFWbDdueGpWM0pCWlZxMXBLa1kyeTFRaE5oaklMTjlkZjF0dWVkTjdoQVk5bDg3dF9VV0ZXTnhjSEg5VHVfMzdQNnQzX21ra1JJWVIw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQWUh1ZHFYWXhxVHp3Sjd4TG1XOHJTbHdWLS1kYk1GMVdscXlxR0ZkMUFNcFRNT1Q3eDlEMDBOWEZtV3c5dlUzUjVJXzJzTElCbW5lQkwyODhBUW9xT2V6NlpLNkpTOHJGYXpwRmNVVkRySDFKbjRHSVZfenNqWmFxLVZRcXFWbDdueGpWM0pCWlZxMXBLa1kyeTFRaE5oaklMTjlkZjF0dWVkTjdoQVk5bDg3dF9VV0ZXTnhjSEg5VHVfMzdQNnQzX21ra1JJWVIw?oc=5\" target=\"_blank\">Amgen's Bemarituzumab Shows Diminished Survival Benefit in Gastric Cancer in Latest ESMO Readout</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Precision Medicine Online</font>",
      "published": "2025-10-21T04:37:57+00:00",
      "source": "Precision Medicine Online"
    },
    {
      "title": "Amgen, AZ's Tezspire gains 2nd FDA nod, upping the ante in its battle with Dupixent - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPVEhJTWc3S29XcUhkWndrSEQtQURwZXJhVlljMGNHcnVCNVAzczF1a3hSOU9kMzJRdUUxT0E0RWtEZnBWYnl1cG1CUHg5LVFOeVJ1czNLTzI5T3E2MmV6YzFYS01SSDhVTGxOVEI3c09CZXFUaXBISnpoYXFwTHFwZl9DelFEVU5XRlJQSnZicGlvUVZoRFNRcEpVQVlJYXZfUk9ydGx6bw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxPVEhJTWc3S29XcUhkWndrSEQtQURwZXJhVlljMGNHcnVCNVAzczF1a3hSOU9kMzJRdUUxT0E0RWtEZnBWYnl1cG1CUHg5LVFOeVJ1czNLTzI5T3E2MmV6YzFYS01SSDhVTGxOVEI3c09CZXFUaXBISnpoYXFwTHFwZl9DelFEVU5XRlJQSnZicGlvUVZoRFNRcEpVQVlJYXZfUk9ydGx6bw?oc=5\" target=\"_blank\">Amgen, AZ's Tezspire gains 2nd FDA nod, upping the ante in its battle with Dupixent</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-10-17T21:12:56+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "product_launches": [
    {
      "title": "Forecast Cut: Will Amgen Inc. (AMG0) stock deliver stable dividends - Product Launch & Low Risk Entry Point Tips - nchmf.gov.vn",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQbEg2SXdxLU80YmdHQnVEQ0VMYl9hYlRieVJmVEpSbWFUYkpKMl9BQy1ISE14S29RT095dVlvaUlJVzdqVHVpdG5MVG5UdS1iTTFYemluX3FxNTh1OFk2Z3NjVjZfa3BCX29MQUN6UGR3NTZfMGNjWEZLX21jN3NNbGI5NGRDRXpLZW40RENsZVgyUjg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxQbEg2SXdxLU80YmdHQnVEQ0VMYl9hYlRieVJmVEpSbWFUYkpKMl9BQy1ISE14S29RT095dVlvaUlJVzdqVHVpdG5MVG5UdS1iTTFYemluX3FxNTh1OFk2Z3NjVjZfa3BCX29MQUN6UGR3NTZfMGNjWEZLX21jN3NNbGI5NGRDRXpLZW40RENsZVgyUjg?oc=5\" target=\"_blank\">Forecast Cut: Will Amgen Inc. (AMG0) stock deliver stable dividends - Product Launch & Low Risk Entry Point Tips</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">nchmf.gov.vn</font>",
      "published": "2025-10-18T06:18:36+00:00",
      "source": "nchmf.gov.vn"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T17:18:39+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S. - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5\" target=\"_blank\">$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-21",
      "close": 301.1400146484375
    },
    "history": [
      {
        "date": "2025-10-13",
        "close": 292.3999938964844
      },
      {
        "date": "2025-10-14",
        "close": 293.8500061035156
      },
      {
        "date": "2025-10-15",
        "close": 297.32000732421875
      },
      {
        "date": "2025-10-16",
        "close": 295.80999755859375
      },
      {
        "date": "2025-10-17",
        "close": 298.80999755859375
      },
      {
        "date": "2025-10-20",
        "close": 303.3299865722656
      },
      {
        "date": "2025-10-21",
        "close": 301.1400146484375
      }
    ],
    "name": "Amgen Inc."
  }
}